000			02659cam a22003378i 4500
005			20260406101633.0
008			240815s2024 nju b 001 0 eng
020			_a978-1-39419-240-3
040			_bEnglish _erda _cURS
050	0	0	_aRC483 _b.G27 2025
082	0	0	_a616.89/18
100	1		_aGee, Siobhan, _eauthor.
245	1	4	_aThe Maudsley prescribing : _bguidelines for mental health conditions in physical illness / _cSiobhan Gee, David M. Taylor.
246	1		_aMaudsley prescribing guidelines for mental health conditions in physical illness
263			_a2411
264		1	_aHoboken, NJ : _bWiley-Blackwell, _c©2025.
300			_a174 pages ; _c25 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aCardiac -- Chronic Obstructive Pulmonary Disorder -- Inflammatory Bowel Disease -- Critical Care -- Surgery -- Dialysis -- Delirium -- End-of-Life Care -- Sickle Cell Disease -- Steroids -- Glaucoma -- Restarting after Overdose -- Non-oral Administration.
520			_a"Psychotropic medications are serious treatments for serious illnesses. Whilst often effective in the medically fit population, they frequently produce disappointing efficacy outcomes in the medically unwell patient. Their use is made more difficult by wide-ranging side effects which may complicate management or worsen symptoms or disease pathology of physical illnesses. Medical illnesses themselves may impact on the pharmacokinetics, pharmacodynamics and physical practicalities of administering psychiatric medications, with implications for their effectiveness and safe use. The availability of information to guide the clinician through drug choice for these patients is limited; research trials frequently exclude the medically unwell, guidelines are written for those without comorbidity, and where policies do exist, they do not account for the multimorbidity frequently seen in real-world practice. Further, prescribing and management of psychotropic medicines in non-mental health specialist settings may be fraught with practical difficulties, including access to medication and experience with its use"-- _cProvided by publisher.
650	1	2	_aPsychotropic Drugs _xtherapeutic use
650	2	2	_aPsychopharmacology _xmethods
650	2	2	_aChronic Disease _xpsychology
650	2	2	_aMental Disorders _xdrug therapy
700	1		_aTaylor, David, _d1963- _eauthor.
776	0	8	_iOnline version: _aGee, Siobhan. _tMaudsley prescribing _dHoboken, NJ : Wiley-Blackwell, 2024 _z9781394192410 _w(DLC) 2024038158
942			_2lcc _cR
999			_c99039 _d99036